BBR has been demonstrated to interact directly with the KCNH6 potassium channel, thereby promoting insulin secretion in a hyperglycemia-dependent manner while also contributing to a reduction in the incidence of hypoglycemic events, highlighting its potential application in the adjunctive treatment of diabetes (Zhao et al., 2021). This evidence concerns the gene KCNH6 and Hyperglycemia.